Is Enlivex Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Enlivex Ltd (ENLV) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Enlivex Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Enlivex Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Enlivex Ltd?

Muslim investors may consider investing in Enlivex Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Enlivex Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Enlivex Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Enlivex Ltd updated?

The Shariah compliance status of Enlivex Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Enlivex Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Enlivex Ltd?

You can check the latest Shariah compliance status of Enlivex Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ENLV Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 30, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Enlivex Ltd (ENLV)

Based on 8 analysts giving stock ratings to Enlivex Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Enlivex Ltd. Stock Analysis ENLV

United States Health Care Micro Cap Report: 2025 Annual

Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. The company is headquartered in Ness Ziona, Central(Hamerkaz) and currently employs 34 full-time employees. The company went IPO on 2014-07-30. The firm focuses on diseases in which macrophages are pathologically reprogrammed, such as solid cancers, sepsis and COVID‑19, where non-homeostatic macrophages contribute significantly to disease severity. By re-establishing macrophage homeostasis, Allocetra has the potential to provide an immunotherapeutic mechanism of action for life-threatening indications defined as unmet medical needs, either as a stand‑alone therapy or in combination with other treatments.

Key Statistics of Enlivex Ltd (ENLV)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.70$0.74

Today's Open

$0.71

Volume

224.92K

P/E Ratio (TTM)

0.14

52 Week Range

$0.66$2.10

Market Cap

194.61M

Avg. Volume

369.85K

Dividend Yield

Financial Metrics & Statements of Enlivex Ltd (ENLV)

FAQ's for Enlivex Ltd (ENLV)

According to Musaffa’s Shariah screening methodology, Enlivex Ltd (ENLV) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.